Désireeé Larenas-Linnemann, Jorge Salas-Hernández, Blanca E Del Río-Navarro, Jorge A Luna-Pech, Elsy Maureen Navarrete-Rodríguez, Laura Gochicoa, María Carmen Cano-Salas, Ulises Noel García-Ramírez, Carmen López-Estrada, José Antonio Ortega-Martell, Ambrosio Aguilar-Aranda, Sergio Caretta-Barradas, Martín Bedolla-Barajas, Robert Camargo, Francisco J Cuevas-Schacht, Margarita Fernández-Vega, Carlos García-Bolaños, Claudia Garrido-Galindo, Alejandro Jiménez-Chobillón, Carlos Juárez-Ortiz, María Carmen Larios-García, Héctor León-Molina, Alejandra Macías-Weinmann, Eric Martínez-Infante, Norma E Martínez-Jiménez, Rocío Esmeralda Mateos-Martínez, Jaime Mellado-Ábrego, Víctor Manuel Mendoza-Romero, Carol Vivian Moncayo-Coello, Sergio Monraz-Pérez, Gabriel Montes, Francisco Ignacio Ignacio Ortiz-Aldana, Carlos Lenin Pliego-Reyes, Adela Reyes, Irasema Rodríguez-Godínez, Héctor Hernán Ruiz-Gutiérrez, Andrés Sánchez-González, César F Segovia-Montero, Saraí Carmen Toral-Freyre, Jorge Vázquez-García
{"title":"[MIA 2021, Comprehensive Asthma Management. Guidelines for Mexico].","authors":"Désireeé Larenas-Linnemann, Jorge Salas-Hernández, Blanca E Del Río-Navarro, Jorge A Luna-Pech, Elsy Maureen Navarrete-Rodríguez, Laura Gochicoa, María Carmen Cano-Salas, Ulises Noel García-Ramírez, Carmen López-Estrada, José Antonio Ortega-Martell, Ambrosio Aguilar-Aranda, Sergio Caretta-Barradas, Martín Bedolla-Barajas, Robert Camargo, Francisco J Cuevas-Schacht, Margarita Fernández-Vega, Carlos García-Bolaños, Claudia Garrido-Galindo, Alejandro Jiménez-Chobillón, Carlos Juárez-Ortiz, María Carmen Larios-García, Héctor León-Molina, Alejandra Macías-Weinmann, Eric Martínez-Infante, Norma E Martínez-Jiménez, Rocío Esmeralda Mateos-Martínez, Jaime Mellado-Ábrego, Víctor Manuel Mendoza-Romero, Carol Vivian Moncayo-Coello, Sergio Monraz-Pérez, Gabriel Montes, Francisco Ignacio Ignacio Ortiz-Aldana, Carlos Lenin Pliego-Reyes, Adela Reyes, Irasema Rodríguez-Godínez, Héctor Hernán Ruiz-Gutiérrez, Andrés Sánchez-González, César F Segovia-Montero, Saraí Carmen Toral-Freyre, Jorge Vázquez-García","doi":"10.29262/ram.v68i5.880","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Asthma continues to be one of the most frequent chronic respiratory diseases in our country. New methods for diagnosis and treatment have been described; accordingly, the international guidelines were renewed.</p><p><strong>Objective: </strong>To create a national platform for the development of updated guidelines, solidly based on evidence: Comprehensive Asthma Management (Spanish acronym: MIA).</p><p><strong>Methods: </strong>MIA uses the ADAPTE method. The MIA development group consists of experts in pulmonology-allergology-methodology and representatives of 13 institutions and societies of specialties that manage asthma. The international reference guidelines (selected with AGREE-II): GINA 2020, GEMA 5.0, BTS/SIGN 2019 and ATS/ERS consensus document 2014-2019 on severe asthma. MIA covers suspected asthma, diagnosis, treatment, and special groups. Key clinical questions were formulated on treatment steps 1-3, biomarkers and severe asthma.</p><p><strong>Results: </strong>Based on evidence, safety, cost and local reality, the core group developed responses. Through a Delphi process the broad MIA development group suggested adjustments until consensus was reached.</p><p><strong>Conclusion: </strong>A document was generated with multiple figures and algorithms, solidly based on evidence about asthma management, adjusted for Mexico with a broad base among different societies that participated in its development. It does not include guidelines for acute asthma.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 Suppl 1 ","pages":"s1-s122"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v68i5.880","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 8
Abstract
Background: Asthma continues to be one of the most frequent chronic respiratory diseases in our country. New methods for diagnosis and treatment have been described; accordingly, the international guidelines were renewed.
Objective: To create a national platform for the development of updated guidelines, solidly based on evidence: Comprehensive Asthma Management (Spanish acronym: MIA).
Methods: MIA uses the ADAPTE method. The MIA development group consists of experts in pulmonology-allergology-methodology and representatives of 13 institutions and societies of specialties that manage asthma. The international reference guidelines (selected with AGREE-II): GINA 2020, GEMA 5.0, BTS/SIGN 2019 and ATS/ERS consensus document 2014-2019 on severe asthma. MIA covers suspected asthma, diagnosis, treatment, and special groups. Key clinical questions were formulated on treatment steps 1-3, biomarkers and severe asthma.
Results: Based on evidence, safety, cost and local reality, the core group developed responses. Through a Delphi process the broad MIA development group suggested adjustments until consensus was reached.
Conclusion: A document was generated with multiple figures and algorithms, solidly based on evidence about asthma management, adjusted for Mexico with a broad base among different societies that participated in its development. It does not include guidelines for acute asthma.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
